Biomarkers in Drug Development: A Handbook of Practice, Application, and Strategy

Note moyenne 0
( 0 avis fournis par GoodReads )
9780470169278: Biomarkers in Drug Development: A Handbook of Practice, Application, and Strategy

New, ship fast, delivered in 5 days No PO Box.

Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.

Quatrième de couverture :

Discover how biomarkers can boost the success rate of drug development efforts

As pharmaceutical companies struggle to improve the success rate and cost–effectiveness of the drug development process, biomarkers have emerged as a valuable tool. This book synthesizes and reviews the latest efforts to identify, develop, and integrate biomarkers as a key strategy in translational medicine and the drug development process. Filled with case studies, the book demonstrates how biomarkers can improve drug development timelines, lower costs, facilitate better compound selection, reduce late–stage attrition, and open the door to personalized medicine.

Biomarkers in Drug Development is divided into eight parts:

  • Part One offers an overview of biomarkers and their role in drug development.

  • Part Two highlights important technologies to help researchers identify new biomarkers.

  • Part Three examines the characterization and validation process for both drugs and diagnostics, and provides practical advice on appropriate statistical methods to ensure that biomarkers fulfill their intended purpose.

  • Parts Four through Six examine the application of biomarkers in discovery, preclinical safety assessment, clinical trials, and translational medicine.

  • Part Seven focuses on lessons learned and the practical aspects of implementing biomarkers in drug development programs.

  • Part Eight explores future trends and issues, including data integration, personalized medicine, and ethical concerns.

Each of the thirty–eight chapters was contributed by one or more leading experts, including scientists from biotechnology and pharmaceutical firms, academia, and the U.S. Food and Drug Administration. Their contributions offer pharmaceutical and clinical researchers the most up–to–date understanding of the strategies used for and applications of biomarkers in drug development.

Biographie de l'auteur :

MICHAEL R. BLEAVINS, PhD, is cofounder of Michigan Technology and Research Institute. He retired from Pfizer/Warner–Lambert/Parke–Davis in 2006 and has twenty–three years of experience in pharmaceutical research, development, and biomarkers with more than sixty–five peer–reviewed publications.

CLAUDIO CARINI, MD, PhD, FRCPath, is Chief Medical Officer and Vice President for Clinical Research at Fresenius. Previously, Claudio served as Global Head of Translational Medicine at MDS and Global Head of Biomarkers at Hoffmann–La Roche. Claudio has more than twenty years of experience in the field of immunology and biomarkers and has authored more than 200 publications in international and domestic peer–reviewed journals.

MALLÉ JURIMA–ROMET, PhD, is Senior Director for Development and Regulatory Services at MDS Pharma Services, where she provides strategic and scientific consulting to pharmaceutical and biotech sponsors, and leads drug development program teams. Mallé has authored over forty peer–reviewed publications and is an adjunct professor at the University of Montreal.

RAMIN RAHBARI, MS, is cofounder and Senior Consultant at Innovative Scientific Management. Previously, Ramin has held positions at Pfizer, Synaptic, and Parke–Davis pharmaceutical companies, leading cross–functional biomarker teams.

Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.

Meilleurs résultats de recherche sur AbeBooks

1.

R. Bleavins
ISBN 10 : 0470169273 ISBN 13 : 9780470169278
Neuf(s) Quantité : 1
Vendeur
firstbookstore
(New Delhi, Inde)
Evaluation vendeur
[?]

Description du livre État : Brand New. Brand New Original US Edition, Perfect Condition. Printed in English. Excellent Quality, Service and customer satisfaction guaranteed!. N° de réf. du libraire AIND-93311

Plus d'informations sur ce vendeur | Poser une question au libraire

Acheter neuf
EUR 145,51
Autre devise

Ajouter au panier

Frais de port : Gratuit
De Inde vers Etats-Unis
Destinations, frais et délais

2.

BLEAVINS MICHAEL R. ET.AL
ISBN 10 : 0470169273 ISBN 13 : 9780470169278
Neuf(s) Quantité : 2
Vendeur
Bookshub
(Karol Bagh, Inde)
Evaluation vendeur
[?]

Description du livre État : New. New. US edition. Perfect condition. Ship by express service to USA, Canada, Australia, France, Italy, UK, Germany and Netherland. Customer satisfaction our priority. N° de réf. du libraire ABE-190516-33237

Plus d'informations sur ce vendeur | Poser une question au libraire

Acheter neuf
EUR 147,19
Autre devise

Ajouter au panier

Frais de port : Gratuit
De Inde vers Etats-Unis
Destinations, frais et délais

3.

BLEAVINS MICHAEL R. ET.AL
ISBN 10 : 0470169273 ISBN 13 : 9780470169278
Neuf(s) Quantité : 2
Vendeur
EBOOKSTORE2010
(New Delhi, ND, Inde)
Evaluation vendeur
[?]

Description du livre État : Brand New. New. US edition. Customer Satisfaction guaranteed!!. N° de réf. du libraire SHAK33237

Plus d'informations sur ce vendeur | Poser une question au libraire

Acheter neuf
EUR 147,24
Autre devise

Ajouter au panier

Frais de port : Gratuit
De Inde vers Etats-Unis
Destinations, frais et délais

4.

R. Bleavins
ISBN 10 : 0470169273 ISBN 13 : 9780470169278
Neuf(s) Quantité : 1
Vendeur
Romtrade Corp.
(STERLING HEIGHTS, MI, Etats-Unis)
Evaluation vendeur
[?]

Description du livre État : New. Brand New Original US Edition.We Ship to PO BOX Address also. EXPEDITED shipping option also available for faster delivery. N° de réf. du libraire AUSBNEW-93311

Plus d'informations sur ce vendeur | Poser une question au libraire

Acheter neuf
EUR 152,26
Autre devise

Ajouter au panier

Frais de port : Gratuit
Vers Etats-Unis
Destinations, frais et délais

5.

Bleavins Michael R. Et.Al
ISBN 10 : 0470169273 ISBN 13 : 9780470169278
Neuf(s) Quantité : 1
Vendeur
Basi6 International
(Irving, TX, Etats-Unis)
Evaluation vendeur
[?]

Description du livre État : Brand New. Ships from multiple locations. FedEx or DHL 4-6 business days delivery to your doorstep. N° de réf. du libraire 20JULY16APP-18055

Plus d'informations sur ce vendeur | Poser une question au libraire

Acheter neuf
EUR 152,27
Autre devise

Ajouter au panier

Frais de port : Gratuit
Vers Etats-Unis
Destinations, frais et délais

6.

R. Bleavins
ISBN 10 : 0470169273 ISBN 13 : 9780470169278
Neuf(s) Quantité : 1
Vendeur
Basi6 International
(Irving, TX, Etats-Unis)
Evaluation vendeur
[?]

Description du livre État : Brand New. Ships from multiple locations. FedEx or DHL 4-6 business days delivery to your doorstep. N° de réf. du libraire 20JULY16APP-18054

Plus d'informations sur ce vendeur | Poser une question au libraire

Acheter neuf
EUR 152,27
Autre devise

Ajouter au panier

Frais de port : Gratuit
Vers Etats-Unis
Destinations, frais et délais

7.

BLEAVINS MICHAEL R. ET.AL
ISBN 10 : 0470169273 ISBN 13 : 9780470169278
Neuf(s) Quantité : 1
Vendeur
BooksForStudent
(West Bloomfield, MI, Etats-Unis)
Evaluation vendeur
[?]

Description du livre État : New. Brand New Book In Mint Condition. Shipping With Trackable Method. No APO/FPO Addresses Please. N° de réf. du libraire 9780470169278NHS

Plus d'informations sur ce vendeur | Poser une question au libraire

Acheter neuf
EUR 154,69
Autre devise

Ajouter au panier

Frais de port : Gratuit
Vers Etats-Unis
Destinations, frais et délais

8.

Edité par John Wiley and Sons Ltd, United States (2010)
ISBN 10 : 0470169273 ISBN 13 : 9780470169278
Neuf(s) Couverture rigide Quantité : 1
Vendeur
The Book Depository
(London, Royaume-Uni)
Evaluation vendeur
[?]

Description du livre John Wiley and Sons Ltd, United States, 2010. Hardback. État : New. 236 x 162 mm. Language: English . Brand New Book. By focusing on how to identify, develop, and integrate biomarkers into drug development, this book will improve biomarker use and enhance pharmaceutical decision making. The coverage includes case studies showing how biomarkers can substantively impact drug development timelines and costs, enable better compound selection and reduce late stage attrition, and facilitate personalized medicine. It describes biomarker technologies, characterization and validation, and applications including in discovery, preclinical safety assessment, clinical trials, and translational medicine. The text, a useful resource for the pharmaceutical industry, also looks at practical issues and intellectual property concerns. N° de réf. du libraire AAH9780470169278

Plus d'informations sur ce vendeur | Poser une question au libraire

Acheter neuf
EUR 159,45
Autre devise

Ajouter au panier

Frais de port : Gratuit
De Royaume-Uni vers Etats-Unis
Destinations, frais et délais

9.

Michael R. Bleavins
Edité par Wileyand#8211;Blackwell (2010)
ISBN 10 : 0470169273 ISBN 13 : 9780470169278
Neuf(s) Quantité : 1
Vendeur
Books2Anywhere
(Fairford, GLOS, Royaume-Uni)
Evaluation vendeur
[?]

Description du livre Wileyand#8211;Blackwell, 2010. HRD. État : New. New Book. Shipped from UK in 4 to 14 days. Established seller since 2000. N° de réf. du libraire FW-9780470169278

Plus d'informations sur ce vendeur | Poser une question au libraire

Acheter neuf
EUR 149,46
Autre devise

Ajouter au panier

Frais de port : EUR 10,56
De Royaume-Uni vers Etats-Unis
Destinations, frais et délais

10.

Edité par John Wiley and Sons Ltd, United States (2010)
ISBN 10 : 0470169273 ISBN 13 : 9780470169278
Neuf(s) Couverture rigide Quantité : 1
Vendeur
The Book Depository US
(London, Royaume-Uni)
Evaluation vendeur
[?]

Description du livre John Wiley and Sons Ltd, United States, 2010. Hardback. État : New. 236 x 162 mm. Language: English . Brand New Book. By focusing on how to identify, develop, and integrate biomarkers into drug development, this book will improve biomarker use and enhance pharmaceutical decision making. The coverage includes case studies showing how biomarkers can substantively impact drug development timelines and costs, enable better compound selection and reduce late stage attrition, and facilitate personalized medicine. It describes biomarker technologies, characterization and validation, and applications including in discovery, preclinical safety assessment, clinical trials, and translational medicine. The text, a useful resource for the pharmaceutical industry, also looks at practical issues and intellectual property concerns. N° de réf. du libraire AAH9780470169278

Plus d'informations sur ce vendeur | Poser une question au libraire

Acheter neuf
EUR 160,28
Autre devise

Ajouter au panier

Frais de port : Gratuit
De Royaume-Uni vers Etats-Unis
Destinations, frais et délais

autres exemplaires de ce livre sont disponibles

Afficher tous les résultats pour ce livre